- Home
- WAFDP vs LYEL Comparison
WAFDP vs LYEL Comparison
Compare WAFDP & LYEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WAFDP
- LYEL
- Stock Information
- Founded
- WAFDP N/A
- LYEL 2018
- Country
- WAFDP United States
- LYEL United States
- Employees
- WAFDP 2208
- LYEL N/A
- Industry
- WAFDP Major Banks
- LYEL Biotechnology: Pharmaceutical Preparations
- Sector
- WAFDP Finance
- LYEL Health Care
- Exchange
- WAFDP Nasdaq
- LYEL Nasdaq
- Market Cap
- WAFDP N/A
- LYEL 263.9M
- IPO Year
- WAFDP N/A
- LYEL 2021
- Fundamental
- Price
- WAFDP $17.10
- LYEL $0.66
- Analyst Decision
- WAFDP
- LYEL Sell
- Analyst Count
- WAFDP 0
- LYEL 2
- Target Price
- WAFDP N/A
- LYEL $1.00
- AVG Volume (30 Days)
- WAFDP N/A
- LYEL 1.4M
- Earning Date
- WAFDP N/A
- LYEL 02-26-2025
- Dividend Yield
- WAFDP N/A
- LYEL N/A
- EPS Growth
- WAFDP N/A
- LYEL N/A
- EPS
- WAFDP N/A
- LYEL N/A
- Revenue
- WAFDP N/A
- LYEL $63,000.00
- Revenue This Year
- WAFDP N/A
- LYEL N/A
- Revenue Next Year
- WAFDP N/A
- LYEL N/A
- P/E Ratio
- WAFDP N/A
- LYEL N/A
- Revenue Growth
- WAFDP N/A
- LYEL N/A
- 52 Week Low
- WAFDP N/A
- LYEL $0.58
- 52 Week High
- WAFDP N/A
- LYEL $3.26
- Technical
- Relative Strength Index (RSI)
- WAFDP 35.92
- LYEL 35.21
- Support Level
- WAFDP $16.66
- LYEL $0.60
- Resistance Level
- WAFDP $17.57
- LYEL $0.71
- Average True Range (ATR)
- WAFDP 0.31
- LYEL 0.06
- MACD
- WAFDP -0.07
- LYEL 0.01
- Stochastic Oscillator
- WAFDP 20.59
- LYEL 24.66
About WAFDP WaFd Inc. Depositary Shares
WaFd Inc is engaged in providing lending, depository, insurance, and other banking services to consumers, mid-sized to large businesses, and owners and developers of commercial real estate. Through the WaFd Bank, it is involved in accepting deposits from the general public and investing these funds in loans of various types, including first-lien mortgages on single-family dwellings, construction loans, land acquisition and development loans among others. The Bank also invests in certain United States government and agency obligations along with other investments and also performs insurance brokerage activities. Geographically, it operates in Washington, Oregon, Idaho, Arizona, Utah, Nevada, New Mexico, California and Texas.
About LYEL Lyell Immunopharma Inc.
Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.